NANOTEARS Trademark

Trademark Overview

On Monday, August 2, 2010, a trademark application was filed for NANOTEARS with the United States Patent and Trademark Office. The USPTO has given the NANOTEARS trademark a serial number of 85097928. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, May 13, 2024. This trademark is owned by Altaire Pharmaceuticals, Inc.. The NANOTEARS trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of eye diseases and conditions, namely, an ophthalmic solution formulation and topical preparation that contains colloidal lipids (nanolipids), emulsifiers, and multiple aqueous tearlike ingredients, combined with a unique gelling agent, which when the solution is instilled into the eye increases the viscosity of the solution so that the gelling agent forms a clear gel in the eye for the treatment of ocular disorders as recommended or prescribed by ophthalmologists, eye surgeons, and optometrists and can act as drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; an ophthalmic solution that contains a unique gelling agent applicable to the delivery of active ingredients into the eye to lubricate the eye and provide dry eye relief, redness relief, allergy relief, and is applicable to the delivery into the eye of anti-infectives, antibiotics, and combination anti-fungals, anti-virus and ant...
nanotears

General Information

Serial Number85097928
Word MarkNANOTEARS
Filing DateMonday, August 2, 2010
Status800 - REGISTERED AND RENEWED
Status DateMonday, May 13, 2024
Registration Number4547838
Registration DateTuesday, June 10, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2011

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of eye diseases and conditions, namely, an ophthalmic solution formulation and topical preparation that contains colloidal lipids (nanolipids), emulsifiers, and multiple aqueous tearlike ingredients, combined with a unique gelling agent, which when the solution is instilled into the eye increases the viscosity of the solution so that the gelling agent forms a clear gel in the eye for the treatment of ocular disorders as recommended or prescribed by ophthalmologists, eye surgeons, and optometrists and can act as drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; an ophthalmic solution that contains a unique gelling agent applicable to the delivery of active ingredients into the eye to lubricate the eye and provide dry eye relief, redness relief, allergy relief, and is applicable to the delivery into the eye of anti-infectives, antibiotics, and combination anti-fungals, anti-virus and anti-inflammatory agents
Pseudo MarkNANO TEARS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 6, 2010
Primary Code005
First Use Anywhere DateMonday, August 2, 2010
First Use In Commerce DateSaturday, November 16, 2013

Trademark Owner History

Party NameAltaire Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAquebogue, NY 11931
Party NameAltaire Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAquebogue, NY 11931
Party NameAltaire Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAquebogue, NY 11931

Trademark Events

Event DateEvent Description
Saturday, November 13, 2010NON-FINAL ACTION E-MAILED
Friday, August 6, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 7, 2010NOTICE OF PSEUDO MARK MAILED
Saturday, November 13, 2010ASSIGNED TO EXAMINER
Saturday, November 13, 2010NON-FINAL ACTION WRITTEN
Saturday, November 13, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 22, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 29, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 29, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 29, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 30, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 22, 2010ASSIGNED TO LIE
Wednesday, December 22, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 25, 2011PUBLISHED FOR OPPOSITION
Tuesday, January 25, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, August 22, 2012SOU TEAS EXTENSION RECEIVED
Wednesday, August 31, 2011SOU TEAS EXTENSION RECEIVED
Wednesday, August 31, 2011SOU EXTENSION 1 FILED
Wednesday, August 31, 2011SOU EXTENSION 1 GRANTED
Friday, September 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2012SOU TEAS EXTENSION RECEIVED
Monday, February 27, 2012SOU EXTENSION 2 FILED
Tuesday, March 20, 2012SOU EXTENSION 2 GRANTED
Tuesday, March 20, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 21, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 13, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 22, 2012SOU EXTENSION 3 FILED
Tuesday, August 28, 2012SOU EXTENSION 3 GRANTED
Wednesday, August 29, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 22, 2013SOU TEAS EXTENSION RECEIVED
Friday, February 22, 2013SOU EXTENSION 4 FILED
Monday, February 25, 2013SOU EXTENSION 4 GRANTED
Tuesday, February 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2013SOU TEAS EXTENSION RECEIVED
Thursday, August 22, 2013SOU EXTENSION 5 FILED
Monday, September 16, 2013SOU EXTENSION 5 GRANTED
Tuesday, May 6, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 17, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 19, 2014TEAS STATEMENT OF USE RECEIVED
Wednesday, February 19, 2014USE AMENDMENT FILED
Friday, March 28, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, April 21, 2014SU - NON-FINAL ACTION - WRITTEN
Monday, April 21, 2014NON-FINAL ACTION E-MAILED
Monday, April 21, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 6, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 10, 2014REGISTERED-PRINCIPAL REGISTER
Monday, June 10, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 21, 2019NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Saturday, June 10, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, May 7, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 8, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 9, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 11, 2019TEAS SECTION 8 RECEIVED
Friday, June 21, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 21, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, May 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 13, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, May 13, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, May 13, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, January 26, 2024TEAS SECTION 8 & 9 RECEIVED

Related Keywords

nanotears delivery solution agent relief gelling anti contains unique ophthalmic treatment